By Josh White
Date: Tuesday 05 Aug 2025
(Sharecast News) - Pfizer raised its full-year profit forecast on Tuesday after reporting second-quarter earnings and revenue that exceeded Wall Street expectations, driven by strong sales of key products and progress in cost-cutting initiatives.
Holding(s) in Company | 05-Aug-2025 | 17:30 | RNS |
Update on Evaluation Agreement with Stingray Bio | 05-Aug-2025 | 09:53 | RNS |
Director/PDMR Shareholding | 05-Aug-2025 | 09:15 | RNS |
Holding(s) in Company | 05-Aug-2025 | 08:05 | RNS |
Transaction in Own Shares | 05-Aug-2025 | 07:00 | RNS |
Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
Investment Column:BTG | 06-Oct-2011 | The Independent |
Investment Column:Genus | 09-Sep-2011 | The Independent |
Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
Price | 21,042.28 |
Closing Price Change | 55.99 |
% Change | 0.27 % |
05-Aug-25 Close | 21,042.28 |
You are here: research